{"id":"W2569046072","doi":"10.1016/j.jtho.2016.11.362","title":"OA23.03 Second-Line Afatinib for Advanced Squamous Cell Carcinoma of the Lung: Analysis of Afatinib Long-Term Responders in the Phase III LUX-Lung 8 Trial","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Afatinib; Medicine; Internal medicine; Erlotinib; Lung cancer; Oncology; Adenocarcinoma; Post-hoc analysis; Gastroenterology; Lung; Refractory (planetary science); Surgery; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001859028,0.001288684,0.003464465,0.0003095687,0.0003697044,0.002183614,0.0008374669,0.0009930321,0.002932739],"category_scores_gemma":[0.001447591,0.0003306258,0.003344689,0.0005939694,0.0006762523,0.001510985,0.0004118514,0.003236684,0.0008243219],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001318164,"about_ca_system_score_gemma":0.001153831,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009094882,"about_ca_topic_score_gemma":0.0037695,"domain_scores_codex":[0.999233,0.0003153115,0.00005018606,0.0001541266,0.00007889445,0.0001686087],"domain_scores_gemma":[0.9990909,0.0001912585,0.0002064571,0.00009756955,0.00006653856,0.0003473038],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.71473,0.005309905,0.02793605,0.002158854,0.01246587,0.0005965988,0.0003438719,0.006135443,0.01920517,0.0007853101,0.01259938,0.1977336],"study_design_scores_gemma":[0.7193635,0.1495098,0.09530078,0.0002571233,0.008050905,0.002107859,0.0004268883,0.005563209,0.003710803,0.002422309,0.01308506,0.0002017516],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9857906,0.008132946,0.0003425503,0.0009168221,0.0001478365,0.0003866289,0.002358101,0.00009384954,0.001830656],"genre_scores_gemma":[0.9895271,0.00265464,0.0005203377,0.0008614776,0.0001229395,0.0005208993,0.004060658,0.00004119434,0.001690736],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003464465,"threshold_uncertainty_score":0.009831548,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04173091787525284,"score_gpt":0.4870332160086389,"score_spread":0.4453022981333861,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}